Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.
Publication
, Journal Article
Gurbel, PA; Baker, BA; Bailey, WL; Bliden, KP; Tantry, US
Published in: Thromb Haemost
June 2014
Duke Scholars
Published In
Thromb Haemost
DOI
EISSN
2567-689X
Publication Date
June 2014
Volume
111
Issue
6
Start / End Page
1187 / 1190
Location
Germany
Related Subject Headings
- Treatment Outcome
- Ticlopidine
- Ticagrelor
- Thiophenes
- Smoking
- Risk Reduction Behavior
- Purinergic P2Y Receptor Antagonists
- Prasugrel Hydrochloride
- Platelet Aggregation Inhibitors
- Piperazines
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., Baker, B. A., Bailey, W. L., Bliden, K. P., & Tantry, U. S. (2014). Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors. Thromb Haemost, 111(6), 1187–1190. https://doi.org/10.1160/TH13-08-0642
Gurbel, Paul A., Brian A. Baker, William L. Bailey, Kevin P. Bliden, and Udaya S. Tantry. “Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.” Thromb Haemost 111, no. 6 (June 2014): 1187–90. https://doi.org/10.1160/TH13-08-0642.
Gurbel PA, Baker BA, Bailey WL, Bliden KP, Tantry US. Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors. Thromb Haemost. 2014 Jun;111(6):1187–90.
Gurbel, Paul A., et al. “Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.” Thromb Haemost, vol. 111, no. 6, June 2014, pp. 1187–90. Pubmed, doi:10.1160/TH13-08-0642.
Gurbel PA, Baker BA, Bailey WL, Bliden KP, Tantry US. Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors. Thromb Haemost. 2014 Jun;111(6):1187–1190.
Published In
Thromb Haemost
DOI
EISSN
2567-689X
Publication Date
June 2014
Volume
111
Issue
6
Start / End Page
1187 / 1190
Location
Germany
Related Subject Headings
- Treatment Outcome
- Ticlopidine
- Ticagrelor
- Thiophenes
- Smoking
- Risk Reduction Behavior
- Purinergic P2Y Receptor Antagonists
- Prasugrel Hydrochloride
- Platelet Aggregation Inhibitors
- Piperazines